NCT03011931View on ClinicalTrials.gov

Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

February 28, 2019

Conditions
Celiac Disease
Interventions
DRUG

Simvastatin

20 mg Simvastatin given, Blood draw, Urine collection, Celiac serology testing, DNA sampling, Dietary review

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Collaborators (1)

Immunogenics, LLC
All Listed Sponsors
collaborator

Immunogenics, LLC

INDUSTRY

lead

Entero Therapeutics

INDUSTRY

NCT03011931 - Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] | Biotech Hunter | Biotech Hunter